Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01053741 · ClinicalTrials.gov registry record · NA

Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission

A NA study of Human Immunodeficiency Virus (HIV), sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT01053741 is a NA study of Human Immunodeficiency Virus (HIV) that has completed, run by Johns Hopkins University. The registered enrollment target is 11 participants, below the 508-participant average among 18 other Human Immunodeficiency Virus (HIV) trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01053741, a NA study of Human Immunodeficiency Virus (HIV), has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

This research is being done to learn how seminal fluid affects the lining of the colon, and whether this might make it easier for HIV to get into the body and cause infection.

Interventions

  • BIOLOGICAL Radiolabeled autologous seminal fluid
  • BIOLOGICAL Radiolabeled Normosol-R

Study Locations (1)

Maryland

  • Johns Hopkins University Drug Development Unit - Baltimore

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2008-03
Est. Completion 2009-12
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT01053741

The ClinicalTrials.gov registry entry for NCT01053741 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 508-participant average among 18 other Human Immunodeficiency Virus (HIV) trials with a reported enrollment target (98% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Human Immunodeficiency Virus (HIV) appearing as the primary indexed condition, and to 2 interventions - of which Radiolabeled autologous seminal fluid is the first listed.

NCT01053741 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01053741 about?

NCT01053741 is a clinical study titled "Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission". This research is being done to learn how seminal fluid affects the lining of the colon, and whether this might make it easier for HIV to get into the body and cause infection.

What is the current status of trial NCT01053741?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2008-03. Estimated completion is 2009-12.

What conditions does trial NCT01053741 study?

This clinical trial studies the following conditions: Human Immunodeficiency Virus (HIV).

What interventions are being tested in trial NCT01053741?

The interventions under investigation include: Radiolabeled autologous seminal fluid (BIOLOGICAL), Radiolabeled Normosol-R (BIOLOGICAL).

Who is sponsoring clinical trial NCT01053741?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01053741 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Human Immunodeficiency Virus (HIV)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.